Related references
Note: Only part of the references are listed.Pathology of Lung Cancer
William D. Travis
CLINICS IN CHEST MEDICINE (2011)
Performance of 18Fluorodeoxyglucose-Positron Emission Tomography and Somatostatin Receptor Scintigraphy for High Ki67 (≥10%) Well-Differentiated Endocrine Carcinoma Staging
Ronan Abgral et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Somatostatin receptor tissue distribution in lung neuroendocrine tumours: a clinicopathologic and immunohistochemical study of 218 'clinically aggressive' cases
L. Righi et al.
ANNALS OF ONCOLOGY (2010)
18F-Fluorodeoxyglucose Positron Emission Tomography Predicts Survival of Patients with Neuroendocrine Tumors
Tina Binderup et al.
CLINICAL CANCER RESEARCH (2010)
Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET
Tina Binderup et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity
Francis J. Cloran et al.
LUNG CANCER (2010)
A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors
Irfan Kayani et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Predictive Value of 18F-FDG PET and Somatostatin Receptor Scintigraphy in Patients with Metastatic Endocrine Tumors
Etienne Garin et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Functional Imaging of neuroendocrine tumors with combined PET/CT using 68Ga-DOTATATE (Dota-DPhe1,Tyr3-octreotate) and 18F-FDG
Irfan Kayani et al.
CANCER (2008)
Comparison of 68Ga-DOTATOC PET and 111In-DTPAOC (Octreoscan) SPECT in patients with neuroendocrine tumours
I. Buchmann et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2007)
68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors:: Comparison with somatostatin receptor scintigraphy and CT
Michael Gabriel et al.
JOURNAL OF NUCLEAR MEDICINE (2007)
The utility of fluorodeoxyglucose positron emission tomography in the evaluation of carcinoid tumors presenting as pulmonary nodules
Craig E. Daniels et al.
CHEST (2007)
Chemotherapy and role of the proliferation marker Ki-67 in digestive neuroendocrine tumors
Eduardo Vilar et al.
ENDOCRINE-RELATED CANCER (2007)
Use of integrated FDG PET/CT imaging in pulmonary carcinoid tumours
S. Kruger et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Neuroendocrine tumors of the lung: Clinical, pathologic, and imaging findings
Semin Chong et al.
RADIOGRAPHICS (2006)
Somatostatin receptors and their interest in diagnostic pathology
M Volante et al.
ENDOCRINE PATHOLOGY (2004)
Clinical-radiological presentation and outcome of surgically treated pulmonary carcinoid tumours: a long-term single institution experience
L Schrevens et al.
LUNG CANCER (2004)
Pulmonary neuroendocrine tumors: Incidence and prognosis of histological subtypes. A population-based study in Denmark
H Skuladottir et al.
LUNG CANCER (2002)
Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67
T Belhocine et al.
NUCLEAR MEDICINE COMMUNICATIONS (2002)
Bronchial carcinoid tumors: Surgical management and long-term outcome
PL Filosso et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2002)
Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands
JC Reubi et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE (2001)
Pulmonary carcinoid - Presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature
G Fink et al.
CHEST (2001)
Typical and atypical pulmonary carcinoids - outcome in patients presenting with regional lymph node involvement
CF Thomas et al.
CHEST (2001)
Pulmonary atypical carcinoid: Predictors of survival in 106 cases
MB Beasley et al.
HUMAN PATHOLOGY (2000)
Long-term outcome after resection for bronchial carcinoid tumors
MK Ferguson et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2000)
Share Paper
